House Dust Mite Injection Immunotherapy in Elderly Patients.

PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

April 10, 2014

Primary Completion Date

June 20, 2016

Study Completion Date

April 15, 2017

Conditions
Allergen Immunotherapy in Elderly Patients
Interventions
BIOLOGICAL

Purethal Mites

perennial allergren specific immunotherapy during 24 months

OTHER

placebo injection

perrenial injection wich were administered in same protocol as Purethal

DIAGNOSTIC_TEST

monitoring of allergen specific IgE

measurement the serum specific IgE at the start and at the end of trial

DIAGNOSTIC_TEST

monitoring of allergen specific IgG4

measurement the serum specific IgG4 at the start and at the end of trial

All Listed Sponsors
lead

Medical University of Silesia

OTHER

NCT03209245 - House Dust Mite Injection Immunotherapy in Elderly Patients. | Biotech Hunter | Biotech Hunter